• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For March 11, 2024

    3/11/24 4:56:22 AM ET
    $ALTO
    $ASAN
    $ASRT
    $AVO
    Major Chemicals
    Industrials
    Computer Software: Prepackaged Software
    Technology
    Get the next $ALTO alert in real time by email

    Companies Reporting Before The Bell

    • Ballard Power Systems (NASDAQ:BLDP) is estimated to report quarterly loss at $0.13 per share on revenue of $34.20 million.

    • Endeavor Gr Hldgs (NYSE:EDR) is likely to report quarterly earnings at $0.02 per share on revenue of $49.47 million.

    • SilverCrest Metals (AMEX:SILV) is likely to report quarterly earnings at $0.10 per share on revenue of $44.09 million.

    • Global X Silver Miners ETF (NYSE:SIL) is likely to report quarterly earnings at $0.10 per share on revenue of $44.09 million.

    • Legend Biotech (NASDAQ:LEGN) is projected to report quarterly loss at $0.83 per share on revenue of $86.52 million.

    • Genie Energy (NYSE:GNE) is projected to report earnings for its fourth quarter.

    • Overseas Shipholding Gr (NYSE:OSG) is expected to report earnings for its fourth quarter.

    • Eltek (NASDAQ:ELTK) is projected to report quarterly earnings at $0.31 per share on revenue of $12.20 million.

    • Endeavour Silver (NYSE:EXK) is estimated to report quarterly earnings at $0.02 per share on revenue of $49.47 million.

    • Fortrea Holdings (NASDAQ:FTRE) is projected to report quarterly earnings at $0.24 per share on revenue of $775.89 million.

    Companies Reporting After The Bell

    • Hesai Gr (NASDAQ:HSAI) is likely to report quarterly loss at $0.11 per share on revenue of $81.11 million.

    • PLAYSTUDIOS (NASDAQ:MYPS) is expected to report quarterly loss at $0.02 per share on revenue of $75.31 million.

    • Ocular Therapeutix (NASDAQ:OCUL) is estimated to report quarterly loss at $0.30 per share on revenue of $15.71 million.

    • Asana (NYSE:ASAN) is estimated to report quarterly loss at $0.10 per share on revenue of $167.68 million.

    • Calavo Growers (NASDAQ:CVGW) is projected to report quarterly earnings at $0.17 per share on revenue of $252.67 million.

    • Mission Produce (NASDAQ:AVO) is likely to report quarterly loss at $0.06 per share on revenue of $210.75 million.

    • Casey's General Stores (NASDAQ:CASY) is estimated to report quarterly earnings at $2.13 per share on revenue of $3.54 billion.

    • Oracle (NYSE:ORCL) is estimated to report quarterly earnings at $1.38 per share on revenue of $13.31 billion.

    • Cango (NYSE:CANG) is estimated to report earnings for its fourth quarter.

    • Beachbody Co (NYSE:BODI) is estimated to report quarterly loss at $3.12 per share on revenue of $108.75 million.

    • Ranpak Hldgs (NYSE:PACK) is expected to report quarterly loss at $0.04 per share on revenue of $87.04 million.

    • Alto Ingredients (NASDAQ:ALTO) is expected to report quarterly loss at $0.08 per share on revenue of $292.76 million.

    • CytomX Therapeutics (NASDAQ:CTMX) is expected to report quarterly loss at $0.03 per share on revenue of $21.04 million.

    • Yalla Group (NYSE:YALA) is expected to report earnings for its fourth quarter.

    • Assertio Holdings (NASDAQ:ASRT) is projected to report quarterly loss at $0.02 per share on revenue of $33.81 million.

    • Smart Sand (NASDAQ:SND) is expected to report quarterly loss at $0.06 per share on revenue of $57.70 million.

    • Bowman Consulting Group (NASDAQ:BWMN) is likely to report quarterly loss at $0.07 per share on revenue of $90.66 million.

    • LifeMD (NASDAQ:LFMD) is projected to report quarterly loss at $0.14 per share on revenue of $40.49 million.

    • Invesco KBW NASDAQ Fintech UCITS ETF (NASDAQ:FTEK) is estimated to report quarterly loss at $0.03 per share on revenue of $6.90 million.

    • NN (NASDAQ:NNBR) is expected to report quarterly loss at $0.08 per share on revenue of $113.15 million.

    • Alpha Teknova (NASDAQ:TKNO) is expected to report quarterly loss at $0.24 per share on revenue of $8.32 million.

    • Monroe Cap (NASDAQ:MRCC) is estimated to report quarterly earnings at $0.27 per share on revenue of $16.56 million.

    • Vail Resorts (NYSE:MTN) is estimated to report quarterly earnings at $5.98 per share on revenue of $1.15 billion.

    • NET Power (NYSE:NPWR) is projected to report quarterly loss at $0.05 per share on revenue of $1.50 million.

    • Heritage Insurance Hldgs (NYSE:HRTG) is expected to report quarterly earnings at $0.46 per share on revenue of $185.11 million.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ALTO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALTO
    $ASAN
    $ASRT
    $AVO

    CompanyDatePrice TargetRatingAnalyst
    Hesai Group
    $HSAI
    2/10/2026$31.50Outperform
    Macquarie
    Oracle Corporation
    $ORCL
    2/9/2026Buy → Hold
    Melius
    Oracle Corporation
    $ORCL
    2/9/2026$180.00Neutral → Buy
    DA Davidson
    Oracle Corporation
    $ORCL
    2/4/2026$270.00 → $205.00Outperform
    BMO Capital Markets
    Legend Biotech Corporation
    $LEGN
    1/22/2026$21.00Buy → Hold
    TD Cowen
    Casey's General Stores Inc.
    $CASY
    1/21/2026Buy → Neutral
    Northcoast
    CytomX Therapeutics Inc.
    $CTMX
    1/20/2026$10.00Buy
    Guggenheim
    Casey's General Stores Inc.
    $CASY
    1/20/2026$730.00Outperform
    BNP Paribas Exane
    More analyst ratings

    $ALTO
    $ASAN
    $ASRT
    $AVO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Macquarie initiated coverage on Hesai Group with a new price target

    Macquarie initiated coverage of Hesai Group with a rating of Outperform and set a new price target of $31.50

    2/10/26 9:51:02 AM ET
    $HSAI
    Industrial Machinery/Components
    Industrials

    Oracle downgraded by Melius

    Melius downgraded Oracle from Buy to Hold

    2/9/26 9:24:14 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle upgraded by DA Davidson with a new price target

    DA Davidson upgraded Oracle from Neutral to Buy and set a new price target of $180.00

    2/9/26 6:56:02 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ALTO
    $ASAN
    $ASRT
    $AVO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Oracle AI Agents Help Supply Chain Leaders Boost Efficiency and Strengthen Resiliency

    New AI agents embedded in Oracle Fusion Cloud Applications help supply chain professionals act faster, reduce risk, and improve operational performance MUMBAI, Feb. 10, 2026 /PRNewswire/ -- Oracle AI World Tour -- Oracle today announced new AI agents within Oracle Fusion Cloud Applications to help supply chain leaders accelerate decision-making and drive greater efficiency across planning, procurement, manufacturing, maintenance, and logistics. Built using Oracle AI Agent Studio for Fusion Applications, the new AI agents are embedded within supply chain processes to help leaders unlock productivity gains and enhance business performance by automating end-to-end workflows and delivering insig

    2/10/26 3:01:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle Helps Organizations Enhance Process Manufacturing

    New recipe and materials management, batch execution, and compliance capabilities in Oracle Fusion Cloud SCM help customers improve control, enhance quality, and lower risk MUMBAI, India, Feb. 10, 2026 /PRNewswire/ -- Oracle AI World -- Oracle today announced new capabilities in Oracle Fusion Cloud Supply Chain & Manufacturing (SCM) to help organizations manage the unique requirements of process manufacturing. The latest innovations help organizations that produce goods by mixing or blending ingredients improve real-time production visibility and meet regulatory requirements by connecting formulas, recipes, materials, and batch execution in a unified cloud solution.

    2/10/26 3:01:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle AI Agents Help Marketing, Sales, and Service Leaders Enhance Customer Experiences

    New role-based AI agents embedded in Oracle Fusion Cloud Applications transform slow and reactive sales, marketing, and service processes into revenue driving opportunities MUMBAI, Feb. 10, 2026 /PRNewswire/ -- Oracle AI World Tour -- Oracle today announced new role-based AI agents within Oracle Fusion Cloud Applications to help organizations deliver intelligent customer experiences (CX) at scale. Built using Oracle AI Agent Studio for Fusion Applications, the new AI agents are embedded within marketing, sales, and service processes to help CX leaders drive productivity gains and enhance business performance by analyzing unified data, automating processes, and delivering predictive insights

    2/10/26 3:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ALTO
    $ASAN
    $ASRT
    $AVO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Operating Officer Notman Donald sold $101,398 worth of shares (11,490 units at $8.82), decreasing direct ownership by 3% to 377,802 units (SEC Form 4)

    4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)

    2/4/26 8:23:42 PM ET
    $OCUL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Cohler Matt was granted 823 shares, increasing direct ownership by 0.24% to 339,849 units (SEC Form 4)

    4 - Asana, Inc. (0001477720) (Issuer)

    2/4/26 6:02:27 PM ET
    $ASAN
    Computer Software: Prepackaged Software
    Technology

    Director Anderson-Copperman Krista was granted 1,268 shares, increasing direct ownership by 2% to 65,788 units (SEC Form 4)

    4 - Asana, Inc. (0001477720) (Issuer)

    2/4/26 5:49:45 PM ET
    $ASAN
    Computer Software: Prepackaged Software
    Technology

    $ALTO
    $ASAN
    $ASRT
    $AVO
    SEC Filings

    View All

    SEC Form 6-K filed by Cango Inc.

    6-K - Cango Inc. (0001725123) (Filer)

    2/10/26 6:45:26 AM ET
    $CANG
    Computer Software: Prepackaged Software
    Technology

    SEC Form 6-K filed by Eltek Ltd.

    6-K - ELTEK LTD (0001024672) (Filer)

    2/9/26 7:35:31 AM ET
    $ELTK
    Electrical Products
    Technology

    SEC Form 6-K filed by Legend Biotech Corporation

    6-K - Legend Biotech Corp (0001801198) (Filer)

    2/6/26 4:00:03 PM ET
    $LEGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALTO
    $ASAN
    $ASRT
    $AVO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Large owner Globalharvest Holdings Venture Ltd bought $7,761,616 worth of shares (624,302 units at $12.43), increasing direct ownership by 7% to 9,461,588 units (SEC Form 4)

    4/A - Mission Produce, Inc. (0001802974) (Issuer)

    1/26/26 9:17:56 AM ET
    $AVO
    Farming/Seeds/Milling
    Consumer Staples

    Large owner Globalharvest Holdings Venture Ltd bought $4,055,678 worth of shares (309,020 units at $13.12), increasing direct ownership by 3% to 9,770,608 units (SEC Form 4)

    4 - Mission Produce, Inc. (0001802974) (Issuer)

    1/26/26 9:16:45 AM ET
    $AVO
    Farming/Seeds/Milling
    Consumer Staples

    Large owner Globalharvest Holdings Venture Ltd bought $7,761,529 worth of shares (624,295 units at $12.43), increasing direct ownership by 7% to 9,461,581 units (SEC Form 4)

    4 - Mission Produce, Inc. (0001802974) (Issuer)

    1/21/26 6:30:25 PM ET
    $AVO
    Farming/Seeds/Milling
    Consumer Staples

    $ALTO
    $ASAN
    $ASRT
    $AVO
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Assertio Holdings Inc. on Jun 6

    Recent insider transactions at Assertio Holdings Inc. have brought attention to the company's stock activity. On June 6, 2024, Mason Heather L purchased $24,250 worth of shares, acquiring 25,000 units at $0.97 per share. This transaction increased Mason Heather L's direct ownership by 13% to 212,650 units, as reported in the SEC Form 4. Several other notable insider transactions have taken place at Assertio Holdings Inc. leading up to this purchase. Patel Ajay, Schwichtenberg Paul, and Schlessinger Sam all converted options into shares and covered exercise/tax liability by utilizing their shares. These transactions resulted in ownership increases of 16%, 20%, and 21%, respectively. Addition

    6/10/24 1:20:50 AM ET
    $ASRT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALTO
    $ASAN
    $ASRT
    $AVO
    Financials

    Live finance-specific insights

    View All

    Octave Specialty Group to Release Fourth Quarter 2025 Results on February 23, 2026

    Conference Call Scheduled for February 24, 2026 Octave Specialty Group, Inc. (NYSE:OSG), a global specialty insurance firm, will release fourth quarter 2025 results on February 23, 2026, following the close of the market. Conference Call On February 24, 2026, at 8:30am (ET), Claude LeBlanc, President and Chief Executive Officer, and David Trick, Executive Vice President and Chief Financial Officer, will discuss fourth quarter 2025 results during a live conference call. A live audio webcast of the call will be available through the Investor Relations section of Octave's website, www.octavegroup.com. Participants may also listen via telephone by dialing (877) 407-9716 (Domestic) or (201

    2/9/26 8:30:00 AM ET
    $OSG
    Property-Casualty Insurers
    Finance

    Teknova to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    HOLLISTER, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. ("Teknova") (NASDAQ:TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the fourth quarter and full year ended December 31, 2025, on Thursday, February 26, 2026, following the close of market. Teknova will host a webcast and conference call on Thursday, February 26, 2026, beginning at 5:30 p.m. Eastern Time. To access the live webcast, listeners can log onto the call from the Investor Relations section of the Teknova website or by using this l

    2/5/26 4:01:00 PM ET
    $TKNO
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

    SOL-1 Phase 3 superiority trial results remain masked to date SOL-1 data expected to be presented at the 49th Macula Society Annual Meeting Ocular plans to submit NDA for AXPAXLI™ in wet AMD based on SOL-1 52 Week data, pending positive results and planned FDA interactions Completed randomization of 631 subjects in SOL-R Phase 3 non-inferiority trial in December 2025; timing of topline results accelerated and now anticipated in 1Q 2027 HELIOS-3 Phase 3 trial in diabetic retinopathy underway Cash balance of $737.1 million as of December 31, 2025, with expected runway into 2028 BEDFORD, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, "Ocula

    2/5/26 7:00:00 AM ET
    $OCUL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALTO
    $ASAN
    $ASRT
    $AVO
    Leadership Updates

    Live Leadership Updates

    View All

    Cango Inc. Completes Bitcoin Sale to Strengthen Financial Position and Advance AI Transformation

    DALLAS, Feb. 9, 2026 /PRNewswire/ -- Cango Inc. (NYSE:CANG) ("Cango" or the "Company"), a leading Bitcoin miner leveraging its global operations to develop an integrated energy and AI compute platform, today announced that, based on a comprehensive assessment of current market conditions and upon approval of the Company's Board of Directors, it completed the sale of 4,451 Bitcoin on the open market during the past weekend, which were settled directly in USDT for aggregate net proceeds of approximately US$305 million in equivalent value. The full amount of the USDT proceeds has been utilized to partially repay a Bitcoin-collateralized loan.

    2/9/26 6:26:00 AM ET
    $CANG
    Computer Software: Prepackaged Software
    Technology

    Cardiff Oncology Announces Executive Leadership Changes as it Transitions to Late-Stage Clinical Development

    SAN DIEGO, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (NASDAQ:CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced a leadership transition designed to support the Company's next phase of growth and advancement toward late-stage development and key clinical and corporate milestones. Mani Mohindru, PhD, a member of Cardiff Oncology's Board of Directors since 2021 and a seasoned biotech executive, has been appointed interim Chief Executive Officer, effective immediately. Mark Erlander, PhD, Chief Executive Officer, and James Levine, Chief Financial Officer, have stepped down from their res

    1/27/26 7:00:00 AM ET
    $CRDF
    $CTMX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Ocular Therapeutix™ Appoints David W. Robinson as Global Chief Commercial Officer

    Accomplished global commercial leader with deep expertise in retina drug launches Primary architect for the industry-defining launch of EYLEA® while at Regeneron Most recently served as Chief Marketing Officer, Global Ophthalmology at Merck BEDFORD, Mass., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, "Ocular")), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that David W. Robinson has agreed to join the Company as Global Chief Commercial Officer. The appointment of Mr. Robinson, a proven commercial leader with a history of launching category-defining therapies, strategically positions Ocular for success

    1/21/26 7:00:00 AM ET
    $OCUL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALTO
    $ASAN
    $ASRT
    $AVO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by NET Power Inc.

    SC 13D/A - NET Power Inc. (0001845437) (Subject)

    11/26/24 9:00:17 PM ET
    $NPWR
    Industrial Machinery/Components
    Energy

    Amendment: SEC Form SC 13G/A filed by Ocular Therapeutix Inc.

    SC 13G/A - OCULAR THERAPEUTIX, INC (0001393434) (Subject)

    11/14/24 5:49:38 PM ET
    $OCUL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Vail Resorts Inc.

    SC 13G/A - VAIL RESORTS INC (0000812011) (Subject)

    11/14/24 4:30:51 PM ET
    $MTN
    Services-Misc. Amusement & Recreation
    Consumer Discretionary